Zu "K04447" wurden 228 Artikel gefunden!

1 von 19 Seiten
Für die Filterung wurden keine Ergebnisse gefunden!
NEU
Anti-JAK2 (9B4), monoclonal
Anti-JAK2 (9B4), monoclonal

Artikelnummer: ELK-EM1368.100

Members of the Janus family of tyrosine kinases (Jak1, Jak2, Jak3 and Tyk2) are activated by ligands binding to a number of associated cytokine receptors. Protein Function: Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates...
Schlagworte: Anti-JAK2, Anti-Janus kinase 2, Anti-Tyrosine-protein kinase JAK2, JAK2 (9B4) Mouse mAb
Anwendung: IHC
Wirt: Mouse
Spezies-Reaktivität: human, mouse, rat
ab 173,00 €
Bewerten
TG-89
TG-89

Artikelnummer: TGM-T20742-100mg

Description: TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 µM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer. Target: JAK, FLT, c-RET. Smiles: Cc1cnc(Nc2cccc(CN3CCOCC3)c2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C. References: FURUKAWA Y, et al....
Anwendung: JAK2 inhibitor
CAS 936091-56-4
MW: 510.65 D
ab 35,00 €
Bewerten
Peficitinib
Peficitinib

Artikelnummer: TGM-T6933-10mg

Description: Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3. Target: Tyrosine Kinases, JAK. Smiles: [H][C@]12CC3C[C@]([H])(CC(O)(C3)C1)C2Nc1c(cnc2[nH]ccc12)C(N)=O. References: Párrizas M, et al. Endocrinology, 1997, 138(4), 1427-1433
Schlagworte: JNJ-54781532, ASP015K
Anwendung: Targets Janus kinase 1 [EC:2.7.10.2] (JAK1)
CAS 944118-01-8
MW: 326.39 D
ab 33,00 €
Bewerten
JAK2 Inhibitor IV
JAK2 Inhibitor IV

Artikelnummer: Cay45230-1

A JAK2 inhibitor (IC50 = 78 nM). SMILES: NC1=NNC2=CC=C(C3=CC=C(S(NC(C)(C)C)(=O)=O)C=C3)C=C21. InChi Code: InChI=1S/C17H20N4O2S/c1-17(2,3)21-24(22,23)13-7-4-11(5-8-13)12-6-9-15-14(10-12)16(18)20-19-15/h4-10,21H,1-3H3,(H3,18,19,20). InChi Key: KFJCXIOVAGJCKB-UHFFFAOYSA-N
Schlagworte: Janus-Associated Kinase 2 Inhibitor IV, 4-(3-amino-1H-indazol-5-yl)-N-(1,1-dimethylethyl)-benzenesulfonamide
Anwendung: JAK2 inhibitor
CAS 1110502-30-1
MW: 344.43 D
ab 74,00 €
Bewerten
Ruxolitinib
Ruxolitinib

Artikelnummer: Cay11609-1

Janus-associated kinases (JAKs) are cytoplasmic tyrosine kinases that are required for activating the signaling of certain cytokines and growth factor receptors. A JAK2 gene fusion mutation, JAK2V617F, that causes unchecked activation of various growth factors and cytokines, has been linked to myeloproliferative...
Schlagworte: INCB 018424, betaR-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
Anwendung: Jak1/2 inhibitor
CAS 941678-49-5
MW: 306.4 D
ab 45,00 €
Bewerten
Ruxolitinib phosphate
Ruxolitinib phosphate

Artikelnummer: TGM-T3043-5mg

Description: Ruxolitinib phosphate (INCB018424)(INCB018424 phosphate) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Target: Autophagy, Mitophagy, JAK. Smiles: OP(O)(O)=O.N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12....
Schlagworte: INCB018424, INC 424 phosphate, INC424, INCB018424 phosphate, Ruxolitinib (INCB-18424) phosphate
Anwendung: Targets Janus kinase 1 [EC:2.7.10.2] (JAK1)
CAS 1092939-17-7
MW: 404.36 D
ab 42,00 €
Bewerten
COVID-19 Forschung
Ruxolitinib
Ruxolitinib

Artikelnummer: AG-CR1-3624-M025

White to off-white solid. Soluble in DMSO or ethanol. Insoluble in water. Antineoplastic, anti-inflammatory and immunomodulating agent, Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50 = 322nM), Affects DC...
Schlagworte: INCB018424, INC 424
Anwendung: JAK1 inhibitor, JAK2 inhibitor
CAS 941678-49-5
MW: 306,4 D
ab 72,00 €
Bewerten
Jak2 (V617F, W659A, W777A, F794H), His-Avi-Tag, Biotin-Labeled
Jak2 (V617F, W659A, W777A, F794H), His-Avi-Tag,...

Artikelnummer: BPS-79498

Human Jak2 with V617F, W659A, W777A, and F794H mutations, GenBank Accession No. NM_004972, a.a. 536-812, with C-terminal His-Avi-Tag, expressed in an Sf9 cell expression system and enzymatically Biotin-labeled using AviTag(TM) technology. MW=35 kDa.
Schlagworte: JAK-2, Janus kinase 2, Tyrosine-protein kinase JAK2,
Anwendung: Kinase assays
Exprimiert in: Insect cells
Ursprungsart: human
MW: 35 kD
573,00 €
Bewerten
JAK2-His-Avi-Tag, Biotin-Labeled
JAK2-His-Avi-Tag, Biotin-Labeled

Artikelnummer: BPS-79074

Human Jak2 (GenBank Accession No. NM_004972), (a.a. 513-827) with C-terminal His-Avi-tag, MW=39 kDa, expressed in an Sf9 expression system. This protein was biotinylated using AviTag(TM) technology.
Schlagworte: JAK-2, Janus kinase 2, Tyrosine-protein kinase JAK2,
Anwendung: WB positive control
Exprimiert in: insect cells
Ursprungsart: human
MW: 39 kD
566,00 €
Bewerten
JAK Inhibitor I
JAK Inhibitor I

Artikelnummer: Cay15146-1

Janus-associated kinases (JAKs) are cytoplasmic tyrosine kinases that are required for activating the signaling of certain cytokines and growth factor receptors. JAK1 mostly activates IL-6, whereas JAK1 and JAK3 trigger IL-2 and IL-4 and JAK1 and JAK2 stimulates IFN-gamma. JAK Inhibitor I is a pyridine-containing...
Schlagworte: CMP 6, Janus-Associated Kinase Inhibitor I, Pyridone 6,...
Anwendung: JAK2, JAK3, JAK1 inhibitor
CAS 457081-03-7
MW: 309.3 D
ab 45,00 €
Bewerten
Anti-JAK2
Anti-JAK2

Artikelnummer: A302-178A

Protein function: Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with...
Schlagworte: Anti-JAK2, Anti-JAK-2, Anti-Janus kinase 2, Anti-Tyrosine-protein kinase JAK2
Anwendung: WB, IP, IHC
Wirt: Rabbit
Spezies-Reaktivität: human
ab 165,00 €
Bewerten
AG-490
AG-490

Artikelnummer: Cay10010311-5

Protein tyrosine kinase (Ptk) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of Ptks. Tyrphostins are a class of antiproliferative compounds which act as Ptk blockers. Leukemic cells from patients in relapse have constitutively activated JAK2 Ptk. AG-490 is an inhibitor of...
Schlagworte: Tyrphostin AG-490, (2E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-2-propenamide
Anwendung: JAK2 inhibitor
CAS 133550-30-8
MW: 294.3 D
ab 51,00 €
Bewerten
1 von 19 Seiten